Literature DB >> 23548513

High prevalence of autoimmune thyroiditis in children and adolescents with vitiligo.

Marije W Kroon1, Charlotte Vrijman, Charlotte Chandeck, Bas S Wind, Albert Wolkerstorfer, Rosalie M Luiten, Jan D Bos, Ronald B Geskus, Paul van Trotsenburg, J P Wietze van der Veen.   

Abstract

BACKGROUND/AIMS: Vitiligo is considered to be an autoimmune disease and is known to be associated with other autoimmune diseases, particularly affecting the thyroid. In children and adolescents this association has been reported in only a few studies, with varying results. The aim of this study was to examine thyroid function and prevalence of thyroid autoimmunity in children and adolescents with vitiligo and to investigate the utility of screening.
METHODS: Two hundred and sixty patients with vitiligo were enrolled. Plasma TSH, FT4 and anti-thyroid peroxidase (TPO) antibody concentrations were measured. The prevalence of thyroid dysfunction and autoimmunity were compared to the general healthy paediatric population.
RESULTS: Autoimmune thyroiditis (AIT) with thyroid hormone disturbances was diagnosed in 16 patients (6.2%). This is significantly higher than the prevalence reported in the general healthy paediatric population. Increased levels of anti-TPO antibodies (= 30 kU/l), without thyroid hormone disturbances, were found in 27 patients (10.5%).
CONCLUSION: The prevalence of AIT in children and adolescents with vitiligo is significantly higher than in the general population. It may be advantageous to screen thyroid function and antibody levels in all paediatric patients with non-segmental vitiligo. To strengthen recommendations on screening, research on the burden for patients and cost-effectiveness is needed.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23548513     DOI: 10.1159/000348388

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  6 in total

1.  Skin disease and thyroid autoimmunity in atopic South Italian children.

Authors:  Marcella Pedullà; Vincenzo Fierro; Pierluigi Marzuillo; Francesco Capuano; Emanuele Miraglia Del Giudice; Eleonora Ruocco
Journal:  World J Clin Pediatr       Date:  2016-08-08

2.  A case series pilot study on the combination of 5-aminolevulinic acid and photodynamic therapy (ALA-PDT) for treatment of vitiligo.

Authors:  YunJie Zhang; Hui Lin; XiaoJuan Guo; XianBiao Zou
Journal:  An Bras Dermatol       Date:  2018 Jul-Aug       Impact factor: 1.896

3.  The Prevalence of Thyroid Disorders in Patients With Vitiligo: A Systematic Review and Meta-Analysis.

Authors:  Jinping Yuan; Chong Sun; Shibin Jiang; Yansong Lu; Yuhui Zhang; Xing-Hua Gao; Yan Wu; Hong-Duo Chen
Journal:  Front Endocrinol (Lausanne)       Date:  2019-01-15       Impact factor: 5.555

4.  Establishing a Pediatric Acute-Onset Neuropsychiatric Syndrome Clinic: Baseline Clinical Features of the Pediatric Acute-Onset Neuropsychiatric Syndrome Cohort at Karolinska Institutet.

Authors:  Caroline Gromark; Robert A Harris; Ronny Wickström; AnnaCarin Horne; Maria Silverberg-Mörse; Eva Serlachius; David Mataix-Cols
Journal:  J Child Adolesc Psychopharmacol       Date:  2019-06-05       Impact factor: 2.576

5.  Pediatric Patients with Vitiligo in Eastern China: Abnormalities in 145 Cases Based on Thyroid Function Tests and Immunological Findings.

Authors:  Cheng Xianfeng; Jiang Yuegen; Yin Zhiyu; Yang Yan; Zeng Xuesi; Wang Fenglai; Li Ansheng; Wang Wei
Journal:  Med Sci Monit       Date:  2015-10-23

6.  Thyroid abnormalities in paediatric patients with vitiligo: retrospective study.

Authors:  Demet Kartal; Murat Borlu; Salih Levent Çınar; Ayten Kesikoğlu; Serap Utaş
Journal:  Postepy Dermatol Alergol       Date:  2016-06-17       Impact factor: 1.837

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.